APA (7th ed.) Citation

F, C., F, H., C, G., H, S., N, G., EM, G., . . . Jr, M. W. (2026). mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-08836-5

Chicago Style (17th ed.) Citation

F, Cai, et al. "MTOR Inhibition Enhances the Antitumor Efficacy of Pan-RAF-MEK Blockade by Inhibiting the ATF4-MTHFD2 Pathway." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-08836-5.

MLA (9th ed.) Citation

F, Cai, et al. "MTOR Inhibition Enhances the Antitumor Efficacy of Pan-RAF-MEK Blockade by Inhibiting the ATF4-MTHFD2 Pathway." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-08836-5.